San Diego, CA, United States of America

Stephan James Cripps


Average Co-Inventor Count = 10.5

ph-index = 6

Forward Citations = 487(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
8 patents (USPTO):

Title: **Innovative Contributions of Inventor Stephan James Cripps in Pharmaceutical Advancements**

Introduction

Stephan James Cripps is a prominent inventor based in San Diego, California. He holds a total of eight patents, showcasing his significant contributions to the field of pharmaceuticals. His innovative work focuses on developing compounds that target specific biological pathways, particularly related to cancer and other diseases characterized by unwanted cell proliferation.

Latest Patents

Cripps’s latest patents include groundbreaking research in indazole compounds and pharmaceutical compositions aimed at inhibiting protein kinases. His work on indazole compounds describes their ability to mediate tyrosine kinase signal transduction, which can effectively modulate and inhibit undesirable cell proliferation. Moreover, these pharmaceutical compositions are directed towards therapeutic applications for cancer and diseases associated with abnormal angiogenesis and cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis.

Another significant patent from Cripps involves benzofused heterocyclic amide derivatives of thienopyridines, recognized for their potential as therapeutic agents. This invention outlines compounds represented by a specific formula, alongside their prodrugs, metabolites, and pharmaceutically acceptable derivatives. These compounds are also pivotal in treating hyperproliferative disorders, expanding potential therapeutic options in the field of medicine.

Career Highlights

Stephan James Cripps has made a remarkable impact at Agouron Pharmaceuticals, Inc., where he contributes to research and development in pharmaceutical innovations. His dedication to advancing medical science is evident through his extensive patent portfolio and the subsequent impact of his inventions on treatment options for various conditions.

Collaborations

His collaborative efforts with esteemed colleagues, including Robert Steven Kania and Cynthia Louise Palmer, have fostered a dynamic research environment. Their combined expertise has enabled significant advancements in therapeutic agents, strengthening the foundation of Cripps's inventive contributions.

Conclusion

In summary, Stephan James Cripps exemplifies the spirit of innovation within the pharmaceutical industry. His patents not only showcase his inventive prowess but also underline the profound impact that targeted therapeutic agents can have in treating serious health conditions. As a notable figure in San Diego's research landscape, Cripps continues to push the boundaries of science with his pioneering work in pharmaceutical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…